Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer

As a regulatory subunit of cyclin kinase, CKS1B promotes cancer development and is associated with poor prognosis in multiple cancer patients. However, the intrinsic role of CKS1B in pancreatic cancer remains elusive. In our research, CKS1B expression in pancreatic tumor tissue was higher than that...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lincheng, Wang, Jing, Zhang, Zhuochao, Yang, Qiyue, Deng, Zhaoda, Zou, Wenbo, Ge, Xinlan, Pan, Ke, Li, Chonghui, Liu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668883/
https://www.ncbi.nlm.nih.gov/pubmed/36405738
http://dx.doi.org/10.3389/fimmu.2022.1052768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668883/
https://www.ncbi.nlm.nih.gov/pubmed/36405738
http://dx.doi.org/10.3389/fimmu.2022.1052768

Ejemplares similares